EUCTR2010-023636-17-NL进行中（未招募）1 期
Intravitreal versus submacular injection of rtPA for acute submacular haemorrhages. - rtPA for acute submacular haemorrhages
The Rotterdam Eye Hospital0 个研究点目标入组 25 人开始时间: 2010年11月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Informed consent
- •- Age > 45
- •- Submacular haemorrhage not existing longer than 14 days at time of surgery
- •- Thickness of SMH at least 1.0 mm
- •- If patient is on anticoagulant drugs: INR<2 (measured during preoperative holding)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- INR>2 (or when treating cardiologist does not allow an INR<2)
- •- Known etiology of SMH other than exudative AMD
- •- Known serious allergy to fluorescein or indocyanine green dye
- •- Immunocompromised
研究者
相似试验
已完成
不适用
Intravitreal versus submacular injection of rtPA for acute submacular haemorrhages.Acute submacular haemorrhages.NL-OMON25583The Rotterdam Eye HospitalPO Box 70030 3000 LM Rotterdam24
已完成
2 期
Intravitreal injection of methotrexate in persistent diabetic macular edemaResistant macular edema in diabetic patients.Distrubtion of retinal layers due to edemaIRCT201610098983N2Guilan University of Medical Sciences,Vice chancellor for research42
招募中
3 期
The Comparison of Efficacy Between Iranian Made Ranibizumab and Imported Ranibizumab in Diabetic Patients with Macular EdemaIRCT20170303032845N1Aracell zist daru154
进行中（未招募）
不适用
Safety and efficacy of intravitreal injections of ranibizumab/Lucentis in combination with verteporfin photodynamic therapy (PDT) in patients with choroidal neovascularisation (CNV) secondary to age related macular degeneratioEUCTR2006-002977-33-SIniversity Eye Hospital10
招募中
1 期
Comparison of the effect of intravitreal injection of bevacizumab (Stevenet) alone with intravitreal injection of bevacizumab and triamcinolone in the treatment of diabetic macular edema with a thickness greater than 500 microns in patientsIRCT20211130053229N1Kerman University of Medical Sciences70